Scancell Plc (LSE: SCLP)
Scancell Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Scancell Plc Company Info
Scancell Holdings Plc engages in the development of novel therapeutic vaccines for the treatment of cancer. Its vaccine platform includes Moditope and ImmunoBody. The company was founded by Lindy Gillian Durrant in 1997 and is headquartered in Oxford, the United Kingdom.
News & Analysis
12-Bagger Scancell Holdings Offers "Positive" Results
Scancell Holdings Plc (LON:SCLP) encouraged by "clinical benefit" from new vaccine.
3 Shares the FTSE 100 Beat Today
Royal Dutch Shell, AstraZeneca, and Scancell Holdings all dip on mixed news.
3 Shares the FTSE 100 Should Beat Today
PZ Cussons, Scancell Holdings, and Bellzone Mining all slip despite positive news.
3 Shares That Beat the FTSE Today
IDOX, Senior, and Scancell Holdings are all climbing.
3 Shares Set to Beat the FTSE Today
Premier Farnell, DS Smith, and Scancell are all on the up.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.